5-Amino-1MQ

Also known as: 5-Amino-1MQ

A pill that aims to switch fat cells from 'storage mode' to 'burning mode' by blocking an enzyme (NNMT) that is overactive in the fat tissue of overweight people. Not technically a peptide, but commonly sold alongside them. Unlike appetite suppressants, this targets the fat cells directly rather than making you eat less. The science is promising in lab studies, but there are no completed human trials yet.

Dosage

50-100 mg oral once or twice daily

Dosages shown are for research reference only. Always consult a qualified healthcare provider.

Half-Life

12-16 hours (limited pharmacokinetic data)

Half-Life Calculator →

Administration

Oral (capsule)

Shop Research-Grade Peptides

99%+ purity · US-based · third-party lab tested

Browse →

Getting Started — Here's What You'll Need

Effects

Fat Metabolism

Shifts adipocytes from fat storage to fat burning by preserving NAD+ and SAM pools.

Metabolic Enhancement

NNMT inhibition activates sirtuin enzymes and mitochondrial biogenesis.

Insulin Sensitivity

Preclinical improvements in glucose handling and cholesterol.

Mechanism of Action

5-Amino-1MQ is a selective inhibitor of nicotinamide N-methyltransferase (NNMT), a cytoplasmic enzyme that is significantly overexpressed in white adipose tissue of obese individuals. NNMT catalyzes the methylation of nicotinamide (a form of vitamin B3) using S-adenosyl methionine (SAM) as the methyl donor, producing 1-methylnicotinamide and S-adenosyl homocysteine. This reaction effectively depletes two critical metabolic cofactors — NAD+ precursors and SAM — from fat cells.

By inhibiting NNMT, 5-Amino-1MQ preserves the cellular pools of both nicotinamide (which feeds NAD+ biosynthesis via the salvage pathway) and SAM (the universal methyl donor required for hundreds of methylation reactions). Increased NAD+ availability activates sirtuin enzymes (particularly SIRT1 and SIRT3), which are master regulators of cellular metabolism — they deacetylate and activate PGC-1alpha (promoting mitochondrial biogenesis), enhance fatty acid oxidation, and suppress lipogenic gene expression. The net effect is that adipocytes shift from a fat-storing to a fat-burning metabolic state.

In preclinical models, NNMT inhibition reduced adipocyte size, decreased total body fat mass, and increased energy expenditure without affecting food intake — suggesting the weight loss mechanism is primarily metabolic rather than appetite-driven. Additionally, NNMT inhibition has shown improvements in insulin sensitivity and reductions in plasma cholesterol. However, all published efficacy data comes from cell culture and rodent studies; no human clinical trials have been completed, so the translational relevance remains uncertain.

Regulatory Status

Not FDA approved. Preclinical research compound. Available through research chemical suppliers and some compounding pharmacies.

Risks & Safety

Common

stomach discomfort, nausea.

Serious

no completed human clinical trials, blocking NNMT could affect important cellular processes that are not yet fully understood.

Compare 5-Amino-1MQ With

Research Papers

60
A novel peptide-based AIE probe for highly selective and ultrasensitive detection of heparin and its applications.

Published: February 7, 2026

AI Summary

Researchers developed a peptide-based fluorescent probe that detects heparin with exceptional sensitivity in under 30 seconds, even in living cells and zebrafish. The probe works by forming nanoaggregates with heparin and could enable portable, point-of-care testing for patients on anticoagulant therapy.

Development and explanation of electrocardiogram-based deep learning for predicting short-term mortality in heart failure patients.

Published: February 12, 2026

AI Summary

A deep learning model was built and validated to predict short-term death risk in heart failure patients using ECG data. With heart failure mortality rising again after years of decline, such tools could help clinicians identify high-risk patients who need more intensive care.

Harnessing Cooperative Hydrogen-Atom Transfer and Nitrene-Primed Radical-Polar Crossover for Asymmetric C-H Amidation of α-Amino Carbonyls.

Published: February 11, 2026

AI Summary

A new copper-catalyzed method enables the creation of chiral nitrogen-containing compounds from amino carbonyls in a way that works with peptides. The approach uses an unconventional reaction pathway that could expand options for synthesizing drug-like molecules.

Discovery of Glycation-Derived Cross-links at Arginine.

Published: February 11, 2026

AI Summary

Scientists identified a new type of sugar-derived cross-link called MIDAL that forms between arginine residues and can become the dominant age-related modification in certain proteins. Understanding these cross-links matters because they are linked to many age-related diseases and may be reversible.

Anti-inflammatory activity and potential anti-inflammatory mechanisms of Artemisia scoparia essential oil.

Published: February 5, 2026

AI Summary

Artemisia scoparia essential oil is known to have antioxidant and anti-inflammatory properties, but how it works remains poorly understood. The abstract frames the need for further research into its mechanisms.

Transcription factor Etv3 controls the tolerogenic function of dendritic cells.

Published: February 11, 2026

AI Summary

The protein Etv3 was identified as a key regulator that keeps dendritic cells in a tolerance-promoting state. When Etv3 was removed in mice, autoimmune-like disease worsened, suggesting it may be relevant to human conditions like lupus.

Evaluating paratransgenesis using engineered symbiotic bacteria for Plasmodium inhibition in mosquito vectors: A systematic review.

Published: February 11, 2026

AI Summary

Engineering mosquito gut bacteria to produce anti-malarial peptides can block parasite development by up to 98% in some setups. The approach could complement existing malaria control, though safety and field testing remain hurdles before wider use.

Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists.

Published: February 11, 2026

AI Summary

GLP-1 drugs show promise in lab models of ALS but current clinical data do not support their use and raise safety concerns, especially around weight loss. More ALS-specific trials are needed before considering these drugs for this population.

Meningeal lymphatic-associated brain swelling in acute stroke.

Published: February 11, 2026

AI Summary

Blocking the VEGF-C-Flt4 pathway reduced brain swelling in rats after stroke by limiting activation of meningeal lymphatic cells. Targeting this pathway could offer a new way to reduce stroke-related inflammation and edema.

Remdesivir may exacerbate ischemic acute kidney injury through molecular alterations in PGC-1α and apoptosis pathways: An in vivo study.

Published: February 11, 2026

AI Summary

In rats with kidney injury, Remdesivir worsened damage by reducing mitochondrial biogenesis and increasing cell death, especially when given subcutaneously. The findings support caution when using Remdesivir in patients with impaired kidney function.

GLP-1 is not enough: can glucagon fill the energy expenditure gap?

Published: February 11, 2026

AI Summary

Weight-loss drugs that mimic GLP-1 mainly reduce appetite but do little to boost energy expenditure. Glucagon receptor agonists may help by increasing fat burning and metabolic rate, potentially improving long-term weight loss when combined with GLP-1 drugs.

Synergistic Effects of Fu Brick Tea Extract and Millet on Antiobesity in High-Fat Diet-Fed Mice through Gut Microbiota Modulation and Activation of the Ffar2-Gcg/Pyy Molecular Pathway.

Published: February 11, 2026

AI Summary

Combining Fu brick tea extract with millet reduced obesity in mice by improving digestion, shifting gut bacteria, and increasing satiety signals. The combination could inform development of starch-based foods that support metabolic health.

An Integrated Strategy for the Discovery, Recombinant Expression, and Biological Evaluation of Anti-Inflammatory Peptides from Rice Protein.

Published: February 11, 2026

AI Summary

A rice-derived peptide called PHP1 was identified, produced in bacteria, and shown to reduce inflammation in cells and mice by blocking NF-κB. The work supports scalable production of anti-inflammatory peptides for functional foods.

One-Step Assembly of Homogeneous DAR4 ADCs via a Traceless Fc Ligand-Directed Acylation Strategy.

Published: February 11, 2026

AI Summary

A one-step method was developed to attach four drug molecules to antibodies with high uniformity. The resulting antibody-drug conjugates showed strong tumor suppression and good stability, advancing options for cancer treatment.

CD4 Mimic-Neutralizing Antibody Conjugates Synthesized by Site-Specific Modification Methods as HIV-1 Entry Inhibitors.

Published: February 11, 2026

AI Summary

Combining a CD4-mimic molecule with a neutralizing antibody into a single conjugate improved anti-HIV activity compared to using both separately. The approach could inform new HIV treatment strategies, though antibody-dependent immune cell killing was reduced.

New-Onset Nonarteritic Anterior Ischemic Optic Neuropathy and Initiators of Semaglutide in US Veterans With Type 2 Diabetes.

Published: February 11, 2026

AI Summary

GLP-1 drugs like semaglutide are widely used for diabetes and weight loss, but emerging reports suggest a possible link to a rare form of vision loss. The abstract highlights the need to weigh this potential risk.

Repurposing loratadine to reverse colistin resistance in Klebsiella pneumoniae through targeting lipid A modification.

Published: December 11, 2026

AI Summary

The allergy drug loratadine restored the effectiveness of colistin against resistant bacteria by blocking a key resistance mechanism. Repurposing existing drugs alongside antibiotics could help combat drug-resistant infections.

Psychometric Validation of the Simplicity of Diabetes Treatment Questionnaire (Sim-Q) for Type 2 Diabetes.

Published: February 11, 2026

AI Summary

The Sim-Q questionnaire was developed to measure how simple or complex diabetes treatment feels to patients. The study evaluated whether the questionnaire is reliable and valid for use in type 2 diabetes.

Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study.

Published: February 11, 2026

AI Summary

Long-term follow-up of Japanese patients receiving peptide receptor radionuclide therapy for neuroendocrine tumors was analyzed for survival and safety. The work addresses gaps in knowledge about durable outcomes of this treatment.

A mathematical model to simulate the biological action of Infliximab on TNF- α in patients with Inflammatory Bowel Disease: the critical role of drug clearance.

Published: February 11, 2026

AI Summary

A mathematical model showed that how quickly the body clears infliximab strongly affects treatment success in inflammatory bowel disease. The model could support personalized dosing and drug monitoring to improve outcomes.

Current and Future Pharmacological Interventions for Acquired Hypothalamic Obesity.

Published: February 11, 2026

AI Summary

Obesity caused by hypothalamic damage is hard to treat with diet and exercise alone, but newer drugs targeting appetite and metabolism show promise. Combination therapies may eventually reduce the need for bariatric surgery in this population.

NOD2-Related Multisystem Inflammatory Disorders and Recent Advances.

Published: February 11, 2026

AI Summary

NOD2 is an immune sensor whose gene variants are linked to several diseases. The review summarizes what is known about these conditions and the biological roles of NOD2.

Modern Management of CKM Syndrome: Use of GLP-1 Receptor Agonists in a Multidisciplinary Setting-Expert Group Recommendations from Kuwait.

Published: February 11, 2026

AI Summary

Kuwaiti experts recommend earlier screening, better coordination across specialties, and broader use of GLP-1 drugs to address the overlapping burdens of obesity, diabetes, heart disease, and kidney disease. Semaglutide was highlighted as a valuable option.

Endothelial miR-7052 Safeguards Blood-Brain Barrier Integrity During Endotoxemia by Co-repressing ANGPT2 and PDE5A.

Published: February 11, 2026

AI Summary

A small RNA called miR-7052 helps protect the blood-brain barrier during sepsis by suppressing two proteins that promote leakage. Restoring or mimicking miR-7052 could be a strategy to limit brain damage in severe infection.

Comparison of long-term and short-term immunogenicity based on two different types of tuberculosis subunit vaccines.

Published: February 11, 2026

AI Summary

A fusion vaccine combining antigens from latent and active tuberculosis triggered stronger immune responses than single antigens in infected people and mice. Both protein and DNA versions of the vaccine showed robust immunogenicity.

mcr gene family evolution and structural mechanisms of colistin resistance: from mcr-1 to emerging variants.

Published: February 11, 2026

AI Summary

Genes that spread colistin resistance among bacteria have evolved into multiple variants and pose a growing threat. The review covers how these genes work, how they spread, and potential countermeasures including surveillance and new inhibitors.

Comparative peptidomic profile and bioactivities of Pacific oyster, Mytilus edulis, Argopecten irradians, Meretrix meretrix L. after simulated gastrointestinal digestion.

Published: February 11, 2026

AI Summary

Four shellfish species were digested in the lab to compare their peptide profiles and potential bioactive effects. The abstract describes the study design without reporting conclusions.

Selective cytotoxicity of microcin H47 against MDA-MB-231 breast cancer cells: an antimicrobial peptide with therapeutic potential.

Published: February 11, 2026

AI Summary

A bacterial peptide called microcin H47 killed triple-negative breast cancer cells while sparing normal cells, largely through apoptosis. The findings support further development of this peptide as a potential cancer treatment.

Neoantigen Vaccine Spurs Broad Immune Responses.

Published: February 10, 2026

AI Summary

A vaccine targeting 209 frameshift peptides produced strong, broad, and durable immune responses in people with Lynch syndrome. The approach could help prevent the multiple cancer types these individuals are at higher risk of developing.

Comprehensive Proteomics and β-Hydroxybutyrylation Profiling in Starvation-Induced Gastrocnemius Muscle Remodeling.

Published: February 5, 2026

AI Summary

During fasting, muscle proteins undergo widespread modification by a ketone-derived tag that may help regulate metabolism. The work reveals how muscle adapts to starvation at the molecular level.

Effects of exogenous detemir and glargine insulin on the detection of endogenous C-peptide and endogenous insulin.

Published: February 11, 2026

AI Summary

The study examined how long-acting insulin analogs affect the ability to measure natural insulin and C-peptide production in the body. Understanding this matters for distinguishing type 1 from type 2 diabetes when patients are already on insulin.

Quiet residents of the vaginal epithelium: immunohistochemical study on the distribution and role of human vaginal Merkel cells.

Published: February 11, 2026

AI Summary

Merkel cells in the vagina may have mechanosensory roles similar to those in skin, but their function there is still unclear. The study aimed to characterize these cells and their potential roles.

An autonomous siRNA delivery system targeting NLRP3: implications in Parkinson's disease.

Published: February 11, 2026

AI Summary

Blocking the NLRP3 inflammasome could offer a new gene therapy approach for Parkinson's, given its role in neuroinflammation. The abstract outlines this rationale without detailing study outcomes.

Development of a prediction model integrating cardiac ultrasound parameters for cardiac complications after distal cholangiocarcinoma surgery: a retrospective cohort study.

Published: February 11, 2026

AI Summary

A new model was developed to predict serious heart complications after surgery for bile duct cancer using preoperative cardiac ultrasound. The tool could help identify high-risk patients before surgery.

Innate lymphoid cells: unsung heroes or villains in multiple sclerosis pathogenesis?

Published: February 12, 2026

AI Summary

Innate lymphoid cells can either worsen or dampen multiple sclerosis depending on subtype and context. Understanding and targeting these cells may lead to more precise treatments for MS.

Activation of cytomegalovirus-encoded G protein-coupled receptor UL33 by an innate N-terminal peptide.

Published: February 11, 2026

AI Summary

A cytomegalovirus protein activates itself using a built-in peptide, which helps the virus hijack host cell signaling. Understanding this mechanism could inform new antiviral strategies.

Targeting the C/EBPβ-PRAME-EZH2 complex modulates the Netrin-4/AKT axis to inhibit renal cancer tumorigenesis and metastasis.

Published: February 11, 2026

AI Summary

A peptide that disrupts a three-protein complex in kidney cancer cells slowed tumor growth and spread in lab models. The findings point to a potential new target for kidney cancer therapy.

Heterogeneity between VIP and GRP neurons underlies AVP receptor signaling in the mouse suprachiasmatic nucleus.

Published: February 11, 2026

AI Summary

Only a small subset of VIP neurons in the brain's clock region responds to vasopressin, and this response helps maintain robust daily rhythms. The work maps how different neuron types communicate within the circadian clock.

Dissection of innate-immune-ligand- and interferon-protein-mediated transcriptional responses in human THP1 cell states.

Published: February 11, 2026

AI Summary

Gene expression in immune cells was mapped in response to different stimuli and genetic perturbations. The dataset helps clarify which transcription factors drive inflammatory responses and how drugs might alter them.

Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products.

Published: February 11, 2026

AI Summary

FDA and industry experts met to discuss how to assess immunogenicity risk for generic peptides and oligonucleotides. The workshop aimed to improve regulatory frameworks for these complex products.

Signal recognition particle-dependent secretome in humans.

Published: February 12, 2026

AI Summary

Most secreted and membrane proteins in human cells depend on the signal recognition particle for proper delivery. The work also identified compensatory pathways and quality control mechanisms when this system is impaired.

Tissue-resident macrophage survival depends on mitochondrial function regulated by SerpinB2 in chronic inflammation.

Published: February 11, 2026

AI Summary

A protein called SerpinB2 helps fat tissue macrophages survive by supporting mitochondrial function. Obesity reduces SerpinB2, contributing to metabolic dysfunction, but restoring it or giving a glutathione precursor improved metabolic health in mice.

PRICE: direct and robust detection of microRNAs at single-nucleotide resolution.

Published: February 11, 2026

AI Summary

A new method called PRICE detects tiny differences in miRNA sequences with high sensitivity, which could improve cancer diagnosis and prognosis. The approach uses peptide nucleic acid blockers with CRISPR to distinguish closely related miRNAs.

Extended Shine-Dalgarno motifs govern translation initiation in Staphylococcus aureus.

Published: February 11, 2026

AI Summary

Staphylococcus aureus uses a distinct mechanism to start protein synthesis that differs from other bacteria. A small leader peptide was also found to control biofilm formation by linking nutrient availability to gene expression.

Estradiol regulates osteoclast sialylation via ST3Gal1 in postmenopausal osteoporosis.

Published: February 11, 2026

AI Summary

Loss of estrogen after menopause turns on a sialylation pathway in bone-eating cells that accelerates bone loss. Blocking this pathway with a sialidase reduced bone loss in mice, suggesting a potential therapeutic target for osteoporosis.

Targeting coronaviral inflammation: aptamer-based strategies for emerging threats.

Published: February 12, 2026

AI Summary

An aptamer that binds a conserved coronavirus protein blocked inflammation across multiple coronaviruses. A combined aptamer-antisense construct reduced viral load and lung inflammation in mice, offering a template for future pandemic preparedness.

Peptide-Directed Chiral Gold Nanozymes for Asymmetric Polymerization and Chirality-Selective Cytotoxicity.

Published: February 11, 2026

AI Summary

Chiral gold nanoparticles guided by peptides catalyzed the formation of mirror-image polymers with different cancer-killing effects. The approach could support development of chirality-selective cancer therapies.

Advanced therapy in familial hypercholesterolemia.

Published: February 12, 2026

AI Summary

A case of a child with familial hypercholesterolemia despite statin therapy prompts a discussion of current options for early diagnosis and treatment. The abstract frames questions about safety and effectiveness in pediatric patients.

New cortisol assay-specific thresholds for the biochemical diagnosis of adrenal insufficiency after ACTH stimulation.

Published: February 12, 2026

AI Summary

Newer cortisol assays may require a lower cutoff than the traditional 18 μg/dL for diagnosing adrenal insufficiency. The study evaluated whether a revised threshold of 15.6 μg/dL improves diagnostic accuracy.

Outcomes of a population-based flash glucose monitoring program in adults with type 2 diabetes mellitus on intensive insulin therapy in Andalusia.

Published: February 12, 2026

AI Summary

Rolling out flash glucose monitoring for adults with type 2 diabetes on intensive insulin poses organizational challenges for health systems. The abstract introduces this topic without reporting outcomes.

Influence of oncostatin M and leukemia inhibitor factor on sarcopenia in individuals with cancer and malnutrition.

Published: February 12, 2026

AI Summary

Oncostatin M and leukemia inhibitory factor are linked to muscle loss in malnutrition. The study aimed to determine their role in sarcopenia in cancer patients with malnutrition.

Exploration of a bioactive oligosaccharide fragment from Saposhnikoviae Radix polysaccharides: preparation, structural characterization, and immunomodulatory mechanism.

Published: April 14, 2026

AI Summary

A sugar fragment from a traditional herb boosted immune function and repaired gut barrier damage in immunosuppressed mice. The work supports development of immunomodulatory products from this plant.

Fructan PKP-1b from Polygonatum kingianum attenuates aging and neurodegeneration by inhibiting insulin/IGF-1 signaling.

Published: April 14, 2026

AI Summary

A sugar from a Chinese medicinal plant extended lifespan and reduced aging-related decline in worms and mice by dampening insulin/IGF-1 signaling. The findings support exploration of this compound for anti-aging applications.

Chronoregulatory and neuroprotective effects of yeast β-glucan against systemic inflammation.

Published: April 14, 2026

AI Summary

Yeast beta-glucan and chicory inulin helped restore normal daily rhythms and reduced brain inflammation in mice with systemic inflammation. The effects were similar to melatonin and ibuprofen, suggesting prebiotics may support circadian and brain health.

An Investigation into the Differentiation of Lactyllysine and Carboxyethyllysine Peptide Modifications by Liquid Chromatography/Mass Spectrometry.

Published: February 11, 2026

AI Summary

Two protein modifications that look identical by standard mass spectrometry were distinguished using chromatography and a specialized fragmentation method. The approach was used to confirm lactylation at a specific site in aldolase across cell types.

Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer.

Published: February 11, 2026

AI Summary

Blocking CXCR4 with an oncolytic virus remodeled blood vessels around ovarian tumors and improved T cell infiltration and anti-tumor activity. The results support combining this approach with adoptive T cell therapy for ovarian cancer.

Tramadol and Its Influence on Platelet Function - An Ex Vivo Study.

Published: February 11, 2026

AI Summary

At typical and higher concentrations, tramadol did not significantly affect platelet function in blood samples from healthy volunteers. The findings support the safety of tramadol regarding bleeding risk, though larger studies are needed.

Investigating protein aggregation in protein-carbohydrate interfaces using sequence and structural features.

Published: February 9, 2026

AI Summary

Regions of proteins that bind sugars often overlap with regions prone to aggregation, and many disease-linked mutations fall in these sites. The work refines understanding of how protein structure, sugar binding, and aggregation interact.

Frequently Asked Questions

What is 5-Amino-1MQ?

A pill that aims to switch fat cells from 'storage mode' to 'burning mode' by blocking an enzyme (NNMT) that is overactive in the fat tissue of overweight people. Not technically a peptide, but commonly sold alongside them. Unlike appetite suppressants, this targets the fat cells directly rather than making you eat less. The science is promising in lab studies, but there are no completed human trials yet.

What is 5-Amino-1MQ used for?

A pill that aims to switch fat cells from 'storage mode' to 'burning mode' by blocking an enzyme (NNMT) that is overactive in the fat tissue of overweight people. Not technically a peptide, but commonly sold alongside them. Unlike appetite suppressants, this targets the fat cells directly rather than making you eat less. The science is promising in lab studies, but there are no completed human trials yet.

What is the dosage for 5-Amino-1MQ?

Research: 50-100 mg oral once or twice daily. No FDA-approved dosing guidelines. No established cycling protocol.

What are the side effects of 5-Amino-1MQ?

Common: stomach discomfort, nausea. Serious: no completed human clinical trials, blocking NNMT could affect important cellular processes that are not yet fully understood.

How does 5-Amino-1MQ work?

5-Amino-1MQ is a selective inhibitor of nicotinamide N-methyltransferase (NNMT), a cytoplasmic enzyme that is significantly overexpressed in white adipose tissue of obese individuals. NNMT catalyzes the methylation of nicotinamide (a form of vitamin B3) using S-adenosyl methionine (SAM) as the methyl donor, producing 1-methylnicotinamide and S-adenosyl homocysteine. This reaction effectively depletes two critical metabolic cofactors — NAD+ precursors and SAM — from fat cells. By inhibiting NNMT, 5-Amino-1MQ preserves the cellular pools of both nicotinamide (which feeds NAD+ biosynthesis via the salvage pathway) and SAM (the universal methyl donor required for hundreds of methylation reactions). Increased NAD+ availability activates sirtuin enzymes (particularly SIRT1 and SIRT3), which are master regulators of cellular metabolism — they deacetylate and activate PGC-1alpha (promoting mitochondrial biogenesis), enhance fatty acid oxidation, and suppress lipogenic gene expression. The net effect is that adipocytes shift from a fat-storing to a fat-burning metabolic state. In preclinical models, NNMT inhibition reduced adipocyte size, decreased total body fat mass, and increased energy expenditure without affecting food intake — suggesting the weight loss mechanism is primarily metabolic rather than appetite-driven. Additionally, NNMT inhibition has shown improvements in insulin sensitivity and reductions in plasma cholesterol. However, all published efficacy data comes from cell culture and rodent studies; no human clinical trials have been completed, so the translational relevance remains uncertain.

How is 5-Amino-1MQ administered?

5-Amino-1MQ is administered via oral (capsule).

What is the half-life of 5-Amino-1MQ?

The half-life of 5-Amino-1MQ is 12-16 hours (limited pharmacokinetic data).

Is 5-Amino-1MQ legal?

Not FDA approved. Preclinical research compound. Available through research chemical suppliers and some compounding pharmacies.

Related Peptides

Adipotide

An extreme experimental approach to fat loss — it physically destroys the blood vessels that feed fat tissue, starving fat cells until they die. Originally developed using anti-cancer technology at MD Anderson Cancer Center. While it did reduce fat in monkey studies, it also caused serious kidney damage, which has effectively stopped its development. Not available for human use.

Weight Loss

AICAR

A natural compound that activates your cells' energy sensor — the same pathway that turns on during exercise. Mimics the metabolic effects of endurance exercise at the cellular level, helping with fat burning, glucose uptake, and building more mitochondria. Banned by WADA as a metabolic modulator after detection in professional cycling.

MetabolicBodybuilding

AOD-9604

A small piece of human growth hormone (amino acids 176-191) designed to keep only the fat-burning effects while removing the unwanted side effects of full growth hormone (like swelling and blood sugar problems). The idea is promising — burn fat without the downsides — but it failed to show significant weight loss in clinical trials. Still widely used in research and wellness clinics despite the weak clinical evidence.

Weight Loss

Cagrilintide

A long-acting version of amylin, a natural hormone your body releases after eating that tells your brain you're full. It works through a completely different pathway than GLP-1 drugs like semaglutide, which is why combining them (as CagriSema) produces even better results. On its own, it reduces how much you eat per meal by signalling fullness earlier. Developed by Novo Nordisk, mainly as part of the CagriSema combination.

Weight Loss